Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients

Transplant International

Volumn 13, Issue 5, 2000, Pages 344-350

  Madden, R L ^a,b   Mulhern, J G ^a   Benedetto, B J ^a   O'Shea, M H ^a   Germain, M J ^a   Braden, G L ^a   O'Shaughnessy, J ^a   Lipkowitz, G S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Acute rejection; Chronic rejection; Renal transplantation

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; IOTALAMATE SODIUM; OKT 3; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033803492     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb01008.x     Document Type: Article

References (24)

1. Risk factors for chronic rejection in renal allograft recipients
2. Early versus late acute renal allograft rejection: Impact on chronic rejection
3. Prediction of creatinine clearance from serum creatinine
4. Impact of acute rejection and early allograft function on renal allograft survival
5. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients
6. Causes of graft loss beyond two years in the cyclosporine era
7. Acute rejection episodes - Best predictor of long-term primary cadaveric renal transplant survival
8. Predictive value of doppler ultrasonography in renal transplantation
9. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants
10. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss
11. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection
12. Rejection episodes
13. Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes
14. Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection
15. Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity
16. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors
17. The impact of an acute rejection episode on long-term renal allograft survival (t1/2)
18. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients
19. Determinants of graft survival after renal transplantation
20. Noncompliance in organ transplant recipients
21. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection
22. OKT3 for primary therapy of the first rejection episode in kidney transplants
23. Predictors of long-term primary cadaveric renal transplant survival
24. Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery